Browse by Supervisor

Lom, Hannah (2013). An investigation of FcRL4 positive B cells in the rheumatoid synovium and The development of a cultured ELISPOT assay for the detection of low frequency t cell responses. University of Birmingham. M.Res.

Williams, Anna (2016). Development of MHC class II-restricted TCR gene therapy for epstein barr virus associated malignancies. University of Birmingham. Ph.D.

Petrovic, Kristina (2018). Exploring the therapeutic potential of CAR-engineered T-cells targeting endothelial markers on tumour and inflamed vasculature. University of Birmingham. Ph.D.

Cawkwell, Lewis Blair (2018). Generating and characterising chimeric antigen receptors to target the tumour vasculature. University of Birmingham. Ph.D.

Frumento, Guido (2018). Preclinical development of adoptive T-cell immunotherapy for EBV-associated diseases using third-party donors. University of Birmingham. Ph.D.

Tubb, Vanessa (2013). Project 1: the role of PTPN22.6 in Intermediate Uveitis and Project 2: cord blood mononuclear cells as an alternative source for Chimeric Antigen Receptor-mediated cancer immunotherapy. University of Birmingham. M.Res.

Dowell, Alexander Charles (2010). Studies of human T cell costimulation: potential for the immunotherapy of cancer. University of Birmingham. Ph.D.

Tubb, Vanessa (2017). The development of novel T cell receptor - and chimeric antigen receptor - engineered T cell therapies for the treatment of cancer. University of Birmingham. Ph.D.

Oldham, Kimberley Anne (2012). The recruitment and role of effector and regulatory T cells in renal cell carcinoma. University of Birmingham. Ph.D.